JNCCN study recommends improvements for cancer care at network sites eurekalert.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eurekalert.org Daily Mail and Mail on Sunday newspapers.
Only one in four Black patients with advanced or metastatic non-small cell lung cancer underwent next-generation sequencing before first-line therapy compared with one in three white patients, according to results of a retrospective study.The findings, presented during the virtual ASCO Annual Meeting, reflect the need to improve access to comprehensive genomic testing during the front-line
E-Mail
CLEVELAND - Follow-up data from the landmark SPRINT study of the effect of high blood pressure on cardiovascular disease have confirmed that aggressive blood pressure management lowering systolic blood pressure to less than 120 mm Hg dramatically reduces the risk of heart disease, stroke, and death from these diseases, as well as death from all causes, compared to lowering systolic blood pressure to less than 140 mm Hg. Systolic blood pressure (SBP) is the upper number in the blood pressure measurement, 140/90, for example.
In findings published in the May 20, 2021 issue of the
New England Journal of Medicine, investigators presented new evidence of the effectiveness of reducing SBP to a target range of less than 120 mm Hg.
Personal View: Cleveland is poised to become the mecca for AI in medicine crainscleveland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from crainscleveland.com Daily Mail and Mail on Sunday newspapers.
Date Time
Case Western Reserve awarded $3 million National Cancer Institute grant to apply AI to immunotherapy
Scientists, medical researchers at Case Western Reserve, NYU Langone Health and University Hospitals using machine-learning to predict response to immunotherapy
Medical researchers from Case Western Reserve University, New York University (NYU), and University Hospitals have been awarded a five-year, $3 million National Cancer Institute grant to develop and apply artificial intelligence (AI) tools for predicting which lung cancer patients will respond to immunotherapy.
A unique aspect of the Case Western Reserve-led study is that it will involve testing of their specific AI tools-for the first time during an ongoing clinical trial.